Results 31 to 40 of about 124,821 (247)

Relationship satisfaction and interpartner agreement about acts of physical and psychological aggression: a multilevel analysis

open access: yesBMC Psychiatry, 2017
Background To analyze, in a multilevel context, the impact of individual-level relationship satisfaction on couples’ mean reports of aggression and agreement about acts of physical and psychological aggression.
José Luis Graña   +2 more
doaj   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

open access: yesMolecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang   +8 more
wiley   +1 more source

Prevalence of aggression and associated factors among inpatients with mental illness at tertiary hospitals in Southwestern Uganda

open access: yesBMC Psychiatry
Background In mental health treatment facilities around the world, aggression aimed towards medical personnel and other patients is a serious issue. Types of aggression include; verbal aggression, aggression towards property, self-harm/auto-aggression ...
Badru Kayongo   +3 more
doaj   +1 more source

Screening for lung cancer: A systematic review of overdiagnosis and its implications

open access: yesMolecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz   +12 more
wiley   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

A Conceptual Review of Lab-Based Aggression Paradigms

open access: yesCollabra: Psychology, 2018
Aggression is often defined as a behavior that is done with the intent to harm an individual who is believed to want avoid being harmed (e.g., Baron & Richardson, 1994).
Randy J. McCarthy, Malte Elson
doaj   +1 more source

Are all types of empathy associated with lower aggression in athletes? A cross-sectional study on Iranian athletes

open access: yesBMC Psychology, 2022
Background This study aimed to evaluate the association between cognitive and affective empathy and aggression in a sample of Iranian athletes. Methods We designed a cross-sectional study.
Elham Mahmoudi   +3 more
doaj   +1 more source

TYPE 2 DIABETES MELLITUS: A RISK FACTOR OF AGGRESSION IN ADULTS

open access: yesKhyber Medical University Journal, 2021
OBJECTIVE: To examine the problem of aggression (physical aggression, verbal aggression, anger and hostility) among patients with type 2 diabetes mellitus (T2DM) in comparison to normal adults.
Riffat Sadiq   +5 more
doaj   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

open access: yesMolecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson   +2 more
wiley   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy